Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Income Statement [Abstract]        
Revenue
Operating expenses:        
Research and development expenses (including non-cash stock-based compensation expenses of $417, $520, $814 and $1,009, respectively) 1,322 1,646 2,874 2,995
General and administrative expenses (including non-cash stock-based compensation expenses of $571, $740, $1,229 and $1,511, respectively) 1,681 1,821 3,515 4,081
Total operating expenses 3,003 3,467 6,389 7,076
Loss from operations (3,003) (3,467) (6,389) (7,076)
Interest income 190 287 363 606
Net loss (2,813) (3,180) (6,026) (6,470)
Less: Net loss attributable to noncontrolling interest (23) (41) (52) (76)
Net loss attributable to common shareholders $ (2,790) $ (3,139) $ (5,974) $ (6,394)
Net loss per common share attributable to common shareholders:        
Basic $ (0.09) $ (0.10) $ (0.19) $ (0.20)
Diluted $ (0.09) $ (0.10) $ (0.19) $ (0.20)
Weighted average common shares outstanding:        
Basic 32,202 31,914 32,200 31,677
Diluted 32,202 31,914 32,200 31,677